All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

3 Science-Backed Ways to Lose Weight WITHOUT Ozempic

Dr. Mindy Pelz

Dr. Mindy Pelz

73K views views on YouTubeWatch on YouTube

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 Deep DivesCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For 3 Science-Backed Ways to Lose Weight WITHOUT Ozempic, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Semaglutide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "3 Science-Backed Ways to Lose Weight WITHOUT Ozempic" from Dr. Mindy Pelz. We read the clip as a GLP-1 Deep Dives claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Time-restricted eating (16:8) produced weight loss comparable to standard calorie counting in a 2022 New England Journal of Medicine study

The reason this review is not generic is the source wording and the canonical claim label "glp1 deep dive 3 science backed ways to lose weight without ozempic." In this clip, the useful excerpt is: "Strong female audience demographic" That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Fasting naturally increases endogenous GLP-1 production, creating a milder version of the same mechanism as semaglutide
People who land here are usually comparing the Compounded Semaglutide claim with ozempic, fasting, and alternatives.
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Time-restricted eating (16:8) produced weight loss comparable to standard calorie counting in a 2022 New England Journal of Medicine study

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video is useful as a prompt for better questions, but it should not be treated as a personalized treatment plan.
  • Time-restricted eating (16:8) produced weight loss comparable to standard calorie counting in a 2022 New England Journal of Medicine study
  • Fasting naturally increases endogenous GLP-1 production, creating a milder version of the same mechanism as semaglutide

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Time-restricted eating (16:8) produced weight loss comparable to standard calorie counting in a 2022 New England Journal of Medicine study
  • Fasting naturally increases endogenous GLP-1 production, creating a milder version of the same mechanism as semaglutide
  • Berberine reduces fasting glucose by 25-30% through AMPK activation, addressing the insulin resistance that drives fat storage
  • Resistance training plus HIIT produces better metabolic outcomes for fat loss than steady-state cardio alone, partly by preventing metabolic adaptation
  • Non-pharmaceutical approaches typically produce 10-20 pounds of loss over 6-12 months versus 50-60 pounds from semaglutide
  • These strategies work best for BMI 25-32 and serve as the foundation that makes GLP-1 therapy more effective for higher BMIs

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What If You Cannot Get Ozempic? Or Do Not Want It?

Dr. Mindy Pelz is known for her work on fasting, and this video addresses a question that millions of people are asking: is there a way to get meaningful weight loss results without GLP-1 medications? Her answer is yes, with caveats, and she backs it up with three specific strategies that have clinical evidence behind them.

This is an important video for a specific audience. If you have a BMI over 35 with serious comorbidities, GLP-1 medications are probably the most effective tool available to you right now, and you should not avoid them out of principle. But if you are in the BMI 25-32 range, cannot access or afford GLP-1 drugs, or want to try non-pharmaceutical approaches first, the strategies Dr. Pelz covers are legitimate options with real science supporting them. The key is setting realistic expectations about the magnitude of results compared to what medications can achieve.

Strategy 1: Time-Restricted Eating and Extended Fasting

Dr. Pelz has built her career around fasting protocols, so it is no surprise that this is her first recommendation. What is useful here is the specificity. She does more than say try intermittent fasting. She breaks down different fasting windows and matches them to specific metabolic goals, giving you a framework for deciding which approach fits your situation.

A 16:8 eating window (16 hours fasting, 8 hours eating) is her baseline recommendation. The evidence for this is solid. A 2022 study in the New England Journal of Medicine found that time-restricted eating produced weight loss comparable to standard calorie counting over 12 months. Participants ate only between noon and 8pm, did not consciously restrict calories, and lost an average of 14 pounds over the study period. A separate 2023 meta-analysis pooling data from 27 clinical trials confirmed that time-restricted eating produces statistically significant reductions in body weight, body fat percentage, and waist circumference.

For more aggressive results, she recommends periodic 24-36 hour fasts, done once or twice per week. Extended fasting triggers autophagy, the cellular recycling process where your cells break down damaged components and reuse the raw materials. Autophagy peaks around 24-36 hours into a fast and has been associated with improved metabolic markers, reduced inflammation, and enhanced insulin sensitivity. Animal studies have shown that autophagy activation improves virtually every metabolic parameter studied, and the limited human data suggests similar directional effects.

The mechanism for weight loss from fasting is partly caloric (you eat less when your eating window is shorter) and partly hormonal. Fasting reduces insulin levels, which allows fat cells to release stored fatty acids for energy. Chronically elevated insulin, which is common in people who eat frequently throughout the day and consume significant amounts of refined carbohydrates, keeps fat cells locked in storage mode. By cycling through periods of low insulin, fasting creates metabolic conditions that favor fat oxidation over fat storage.

Dr. Pelz connects this to GLP-1 biology in an interesting way. Fasting naturally increases your body's own GLP-1 production. Studies have shown that time-restricted eating raises endogenous GLP-1 levels, particularly around the time you break your fast. The effect is much smaller than what you get from pharmaceutical semaglutide (endogenous GLP-1 lasts minutes while semaglutide lasts a week), but it is physiologically real and moves the needle in the same direction. Your body's own GLP-1 system is not broken. For many people, it just needs better conditions to work effectively.

Strategy 2: Targeted Supplementation That Actually Has Evidence

Most weight loss supplements are garbage. Dr. Pelz acknowledges this upfront, which makes her supplement recommendations more credible. She focuses on three specific compounds with published clinical data rather than trying to sell you a stack of twelve different pills.

Berberine gets her top recommendation for blood sugar management. The clinical trial data shows it reduces fasting glucose by about 25-30% and improves insulin sensitivity in a way that is comparable to metformin. For someone with insulin resistance (which describes a huge percentage of overweight and obese adults), getting blood sugar under control is often the single biggest lever for weight loss. When insulin is chronically elevated, your body preferentially stores fat and struggles to burn it. Berberine addresses this directly through AMPK activation, improving glucose uptake by muscle cells and reducing glucose output from the liver.

Omega-3 fatty acids at therapeutic doses (2-4 grams of combined EPA and DHA daily) are her second recommendation. The weight loss data on omega-3s alone is modest, but the anti-inflammatory and metabolic benefits are well-established across dozens of clinical trials. Chronic low-grade inflammation disrupts leptin signaling (making your brain less responsive to satiety signals) and promotes insulin resistance. Reducing inflammation through omega-3 supplementation can improve the hormonal environment that governs appetite and fat metabolism. The anti-inflammatory effect also matters for joint health, which becomes relevant when you start exercising more as part of a weight loss plan.

Fiber supplementation is her third pick, specifically viscous fiber like glucomannan or psyllium. Fiber slows gastric emptying, which creates a sense of fullness that lasts longer after meals. This is mechanistically similar to one of semaglutide's effects, though at a much smaller magnitude. Fiber also feeds beneficial gut bacteria that produce short-chain fatty acids, which have their own metabolic benefits including enhanced GLP-1 secretion from intestinal L-cells. A meta-analysis of glucomannan studies found an average weight loss of about 5 pounds over 5-8 weeks, which is modest but meaningful when combined with other interventions and sustained over longer periods.

Strategy 3: Metabolic Exercise, Beyond Cardio

Dr. Pelz pushes back on the standard exercise advice for weight loss, which typically emphasizes cardio above all else. Her argument, supported by a growing body of research, is that resistance training and high-intensity interval training (HIIT) produce better metabolic outcomes than steady-state cardio for most people trying to lose weight and keep it off.

The reason is metabolic rate. Steady-state cardio (jogging, cycling, swimming at a constant pace) burns calories during the activity but does not significantly change your resting metabolic rate afterward. In fact, prolonged steady-state cardio can actually reduce metabolic rate over time through metabolic adaptation, a process where your body becomes more efficient at performing the exercise, burning fewer calories for the same effort. This is why many people hit a weight loss plateau after months of consistent cardio despite maintaining or even increasing their training volume.

Resistance training builds muscle mass, and muscle is metabolically active tissue that burns energy even at rest. Each pound of muscle burns roughly 6-7 calories per day at rest, compared to about 2 calories per day for fat tissue. That difference sounds small per pound, but over 10-20 pounds of added muscle, it adds up to an additional 40-100 calories per day burned at rest. Over a year, that is 14,600 to 36,500 additional calories, equivalent to 4-10 pounds of fat. And that number does not include the calories burned during the training itself or the post-exercise metabolic elevation.

HIIT creates what is called excess post-exercise oxygen consumption (EPOC), commonly known as the afterburn effect. After a HIIT session, your metabolic rate stays elevated for 12-24 hours as your body recovers, replenishes energy stores, and repairs muscle tissue. Studies comparing HIIT to steady-state cardio have consistently found that HIIT produces equal or greater fat loss in less total exercise time, typically 20-25 minutes per session versus 45-60 minutes of steady-state cardio.

Dr. Pelz recommends a simple framework: resistance training 3-4 times per week, focusing on compound movements (squats, deadlifts, presses, rows) that work multiple large muscle groups simultaneously. Add 1-2 HIIT sessions per week, with intervals of 20-30 seconds of maximum effort followed by 60-90 seconds of recovery, for a total of 15-20 minutes per session. This combination builds muscle, elevates metabolic rate, and improves insulin sensitivity, all of which create conditions that favor fat loss.

The Honest Comparison

Dr. Pelz is candid about the magnitude of results you should expect. The three strategies she outlines, used together consistently, can produce 10-20 pounds of weight loss over 6-12 months in most people. That is real and meaningful, and it comes with broad health benefits beyond the scale: improved insulin sensitivity, better cardiovascular fitness, stronger bones, and reduced inflammation. But it is not 50-60 pounds in 68 weeks, which is what the top responders to semaglutide achieve in clinical trials.

The people who will get the most from these non-pharmaceutical approaches are those in the mildly-to-moderately overweight range (BMI 25-32), those with early metabolic dysfunction (prediabetes, mild insulin resistance) that responds well to lifestyle intervention, and those who are consistent over months rather than looking for rapid results. Consistency is the variable that separates people who get results from these strategies and people who do not.

For people with severe obesity (BMI 35+) or established type 2 diabetes, these strategies are still valuable but may not be sufficient as standalone interventions. In those cases, they serve as the foundation that makes GLP-1 therapy more effective when added, rather than as replacements for it. The best outcomes in the clinical literature come from combining medication with structured lifestyle changes, not from either approach alone.

Building Your Plan

If you want to try the non-pharmaceutical route, here is a practical starting point. Begin with a 16:8 eating window. Skip breakfast (or dinner, whichever is easier for you to drop) and eat within an 8-hour window. Do this for two weeks before adding any other changes. This establishes the fasting habit and begins the hormonal shifts that support the rest of the plan.

In week three, add resistance training three times per week. You do not need a gym. Bodyweight exercises, resistance bands, or a basic set of dumbbells will work. Focus on consistency over intensity at first. Building the habit matters more than optimizing the program.

In week four, add berberine at 500mg with your first meal. Monitor how you feel. If GI side effects are tolerable, increase to 500mg twice daily after one week. If you are on any medications, check for interactions before starting.

Get bloodwork at baseline and again at 12 weeks: fasting glucose, fasting insulin, HbA1c, lipid panel, and inflammatory markers (CRP, homocysteine). Let the numbers tell you whether the plan is working for your specific biology. Adjust based on data, not feelings. If the numbers have not moved after 12 weeks of consistent effort, this approach may not be sufficient for your situation, and it may be time to explore pharmaceutical options.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. Mindy Pelz · Dr. Mindy Pelz

73K views views on this video

Strong female audience demographic

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about time-restricted eating (16:8) produced weight loss comparable to standard calorie?

Time-restricted eating (16:8) produced weight loss comparable to standard calorie counting in a 2022 New England Journal of Medicine study

What does the video say about fasting naturally increases endogenous glp-1 production, creating a milder version?

Fasting naturally increases endogenous GLP-1 production, creating a milder version of the same mechanism as semaglutide

What does the video say about berberine reduces fasting glucose by 25-30% through ampk activation, addressing?

Berberine reduces fasting glucose by 25-30% through AMPK activation, addressing the insulin resistance that drives fat storage

What does the video say about resistance training plus hiit produces better metabolic outcomes for fat?

Resistance training plus HIIT produces better metabolic outcomes for fat loss than steady-state cardio alone, partly by preventing metabolic adaptation

What does the video say about non-pharmaceutical approaches typically produce 10-20 pounds of loss over 6-12?

Non-pharmaceutical approaches typically produce 10-20 pounds of loss over 6-12 months versus 50-60 pounds from semaglutide

What does the video say about these strategies work best for bmi 25-32?

These strategies work best for BMI 25-32 and serve as the foundation that makes GLP-1 therapy more effective for higher BMIs

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr. Mindy Pelz, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.